UMIN ID: UMIN000001900
Registered date:23/04/2009
PhaseII study of Dasatinib in patients with chronic myeloid leukemia after Imatinib failure
Basic Information
Recruitment status | Complete: follow-up complete |
---|---|
Health condition(s) or Problem(s) studied | Chronic Myeloid Leukemia (chronic phase) |
Date of first enrollment | 2009/04/01 |
Target sample size | 60 |
Countries of recruitment | Japan |
Study type | Interventional |
Intervention(s) | Dasatinib |
Outcome(s)
Primary Outcome | MMR rate |
---|---|
Secondary Outcome |
Key inclusion & exclusion criteria
Age minimum | 15years-old |
---|---|
Age maximum | 99years-old |
Gender | Male and Female |
Include criteria | |
Exclude criteria | double cancer pregnancy etc |
Related Information
Primary Sponsor | Inter-Michinoku Dasatinib Study(IMIDAS) |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | Inter-Michinoku Dasatinib Study(IMIDAS) |
Secondary ID(s) |
Contact
public contact | |
Name | |
Address | Uchimaru19-1,Morioka,Japan Japan |
Telephone | |
Affiliation | Iwate Medical University hematology/oncology |
scientific contact | |
Name | Yoji Ishida |
Address | Uchimaru19-1,Moriaka,Japan Japan |
Telephone | |
Affiliation | Iwate Medical Unversity, Internal Medicine hematology/oncology |